Il y a eu 50 transactions d'initiés récentes enregistrées pour Precision BioSciences, Inc. (DTIL), dont 20 achats et 30 ventes. Le total des achats d'initiés s'élève à $129.14K et le total des ventes d'initiés à $513.32K.
Les initiés notables ayant une activité récente comprennent Kelly John Alexander, Smith J. Jefferson, Scimeca Dario. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — DTIL
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-18 |
Kelly John Alexander |
Chief Financial Officer |
Vente Informative |
8,149 |
$3.84 |
$31.29K |
125,883 |
| 2026-02-18 |
Smith J. Jefferson |
Chief Research Officer |
Vente Informative |
4,925 |
$3.84 |
$18.91K |
121,926 |
| 2026-02-18 |
Scimeca Dario |
General Counsel and Secretary |
Vente Informative |
4,925 |
$3.84 |
$18.91K |
56,457 |
| 2026-02-18 |
Amoroso Michael |
President and CEO |
Vente Informative |
20,559 |
$3.84 |
$78.95K |
243,392 |
| 2026-02-17 |
Kelly John Alexander |
Chief Financial Officer |
Exercice d'Options (Vente) |
27,584 |
- |
- |
55,166 |
| 2026-02-17 |
Smith J. Jefferson |
Chief Research Officer |
Exercice d'Options (Vente) |
16,667 |
- |
- |
33,333 |
| 2026-02-17 |
Scimeca Dario |
General Counsel and Secretary |
Exercice d'Options (Vente) |
16,667 |
- |
- |
33,333 |
| 2026-02-17 |
Amoroso Michael |
President and CEO |
Exercice d'Options (Vente) |
67,797 |
- |
- |
135,593 |
| 2026-01-22 |
Amoroso Michael |
President and CEO |
Vente Informative |
34,799 |
$4.17 |
$145.11K |
196,154 |
| 2026-01-21 |
Kelly John Alexander |
Chief Financial Officer |
Vente Informative |
15,213 |
$4.03 |
$61.31K |
106,448 |
| 2026-01-21 |
Smith J. Jefferson |
Chief Research Officer |
Vente Informative |
10,200 |
$4.03 |
$41.11K |
110,184 |
| 2026-01-21 |
Scimeca Dario |
General Counsel and Secretary |
Vente Informative |
8,854 |
$4.03 |
$35.68K |
44,715 |
| 2026-01-20 |
Kelly John Alexander |
Chief Financial Officer |
Exercice d'Options (Vente) |
3,888 |
- |
- |
- |
| 2026-01-20 |
Smith J. Jefferson |
Chief Research Officer |
Exercice d'Options (Vente) |
2,500 |
- |
- |
- |
| 2026-01-20 |
Scimeca Dario |
General Counsel and Secretary |
Exercice d'Options (Vente) |
1,978 |
- |
- |
- |
| 2026-01-20 |
Amoroso Michael |
President and CEO |
Exercice d'Options (Vente) |
8,888 |
- |
- |
- |
| 2025-12-16 |
Germano Geno J |
Director |
Achat Informatif |
3,000 |
$4.72 |
$14.16K |
23,883 |
| 2025-12-16 |
Frankel Stanley |
Director |
Achat Informatif |
2,700 |
$4.70 |
$12.69K |
19,478 |
| 2025-12-15 |
Brown Melinda |
Director |
Achat Informatif |
1,381 |
$4.97 |
$6.86K |
23,346 |
| 2025-11-03 |
Kelly John Alexander |
Chief Financial Officer |
Vente Informative |
1,303 |
$6.49 |
$8.46K |
77,298 |
| 2025-11-03 |
Scimeca Dario |
General Counsel and Secretary |
Vente Informative |
665 |
$6.49 |
$4.32K |
28,258 |
| 2025-11-03 |
Amoroso Michael |
President and CEO |
Exercice d'Options (Vente) |
9,444 |
- |
- |
- |
| 2025-11-02 |
Kelly John Alexander |
Chief Financial Officer |
Exercice d'Options (Vente) |
3,605 |
- |
- |
- |
| 2025-11-02 |
Scimeca Dario |
General Counsel and Secretary |
Exercice d'Options (Vente) |
1,835 |
- |
- |
- |
| 2025-11-02 |
Amoroso Michael |
President and CEO |
Exercice d'Options |
9,444 |
- |
- |
118,984 |
| 2025-09-26 |
Frankel Stanley |
Director |
Achat Informatif |
2,700 |
$4.97 |
$13.42K |
16,778 |
| 2025-09-22 |
Brown Melinda |
Director |
Achat Informatif |
1,400 |
$4.89 |
$6.85K |
21,965 |
| 2025-07-03 |
Kelly John Alexander |
Chief Financial Officer |
Vente Informative |
14,827 |
$4.26 |
$63.16K |
73,485 |
| 2025-06-25 |
Brown Melinda |
Director |
Achat Informatif |
1,682 |
$4.14 |
$6.96K |
20,565 |
| 2025-06-25 |
Buehler Kevin |
Director |
Achat Informatif |
5,076 |
$4.16 |
$21.12K |
28,137 |
| 2025-06-03 |
Germano Geno J |
Director |
Attribution de RSU |
21,000 |
- |
- |
21,000 |
| 2025-06-03 |
Brown Melinda |
Director |
Attribution de RSU |
21,000 |
- |
- |
21,000 |
| 2025-06-03 |
Buehler Kevin |
Director |
Attribution de RSU |
21,000 |
- |
- |
21,000 |
| 2025-06-03 |
Frankel Stanley |
Director |
Attribution de RSU |
21,000 |
- |
- |
21,000 |
| 2025-06-03 |
Pire Shari Lisa |
Director |
Attribution de RSU |
21,000 |
- |
- |
21,000 |
| 2025-06-02 |
Kelly John Alexander |
Chief Financial Officer |
Attribution de RSU |
82,750 |
- |
- |
82,750 |
| 2025-06-02 |
Smith J. Jefferson |
Chief Research Officer |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2025-06-02 |
Scimeca Dario |
General Counsel and Secretary |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2025-06-02 |
Amoroso Michael |
President and CEO |
Attribution de RSU |
203,390 |
- |
- |
203,390 |
| 2025-05-27 |
Germano Geno J |
Director |
Exercice d'Options (Vente) |
9,826 |
- |
- |
- |
| 2025-05-27 |
Brown Melinda |
Director |
Exercice d'Options (Vente) |
9,826 |
- |
- |
- |
| 2025-05-27 |
Buehler Kevin |
Director |
Exercice d'Options (Vente) |
9,826 |
- |
- |
- |
| 2025-05-27 |
Frankel Stanley |
Director |
Exercice d'Options (Vente) |
9,826 |
- |
- |
- |
| 2025-05-27 |
Pire Shari Lisa |
Director |
Exercice d'Options (Vente) |
9,826 |
- |
- |
- |
| 2025-03-26 |
Brown Melinda |
Director |
Achat Informatif |
1,839 |
$4.75 |
$8.74K |
9,057 |
| 2025-03-26 |
Buehler Kevin |
Director |
Achat Informatif |
4,523 |
$4.67 |
$21.12K |
13,235 |
| 2025-03-25 |
Germano Geno J |
Director |
Achat Informatif |
3,250 |
$5.30 |
$17.23K |
11,057 |
| 2025-03-24 |
Amoroso Michael |
President and CEO |
Vente Informative |
964 |
$5.56 |
$5.36K |
109,540 |
| 2025-03-21 |
Amoroso Michael |
President and CEO |
Exercice d'Options (Vente) |
3,417 |
- |
- |
- |
| 2025-03-04 |
Smith J. Jefferson |
Chief Research Officer |
Vente Informative |
154 |
$4.91 |
$756.14 |
87,805 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
